Price Controls Aren’t Solutions

Prices for prescription drugs in the U.S. are far too high. There is no denying this sad reality. According to an analysis done by the House Ways and Means Committee,…

Regulatory Action Center Review – July 16, 2020

LIVE @WhiteHouse: Federal Affairs @DanielSavickas Assesses President @realDonaldTrump's Successful Deregulatory Agenda Before the Election! #ampFW https://t.co/1wJIGkdO4z https://t.co/QwzOQufZt9 pic.twitter.com/oGY617rzXE —…

Department of Labor Makes Retirement Saving Easier

One of the main features of the economy under COVID-19 has been the absolute unpredictability of the stock market. Americans everywhere are struggling to save money, especially for retirement. Luckily,…

Regulatory Action Center Review – June 5, 2020

Welcome to FreedomWorks Foundation’s ninth regulatory review of 2020! Our Regulatory Action Center proudly updates you with the latest regulatory actions from the swamp. This week, we bring you a…

Another Step for Transparency at EPA

The Environmental Protection Agency (EPA) announced yesterday changes they’re making to regulations promulgated under the Clean Air Act. This new reform would ensure that the public would be informed of…

Senator Inhofe Socially Distances from the Truth

The Senate Armed Services Committee held a hearing recently, led by Sen. Jim Inhofe (R-Okla.) to further investigate the Federal Communications Commission (FCC) granting Ligado Networks’ application to use spectrum.

Regulatory Action Center Review – May 15, 2020

Welcome to FreedomWorks Foundation’s seventh regulatory review of 2020! Our Regulatory Action Center proudly updates you with the latest regulatory actions from the swamp. This week, we bring you a…